Long-term safety of filgrastim (rhG-CSF) administration: Application of haematopoietic growth factors in healthy individuals [4]

British Journal of Haematology

Volumn 137, Issue 1, 2007, Pages 78-79

  Bacher, Ulrike ^a   Zander, Axel R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Donors; Growth factors; Haematological malignancies; Haematopoietic stem cell transplantation

Indexed keywords

HEMOPOIETIC GROWTH FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; DRUG SAFETY; FAMILIAL INCIDENCE; HEMATOLOGIC MALIGNANCY; HUMAN; LETTER; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; STEM CELL MOBILIZATION;

FILGRASTIM; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RISK; TIME FACTORS; TISSUE DONORS;

EID: 33947278861     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06529.x     Document Type: Letter

References (6)

1. Bennett, C.L., Evens, A.M., Andritsos, L.A., Balasubramanian, L., Mai, M., Fisher, M.J., Kuzel, T.M., Angelotta, C., McKoy, J.M., Vose, J.M., Bierman, P.J., Kuter, D.J., Trifilio, S.M., Devine, S.M. & Tallman, M.S. (2006) Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. British Journal of Haematology, 135, 642-650.
2. Goldman, J.M., Madrigal, J.A. & Pamphilon, D. (2006) Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors. British Journal of Haematology, 135, 651-652.
3. Horowitz, M.M. & Confer, D.L. (2005) Evaluation of hematopoietic stem cell donors. American Society of Hematology Program Book, 1, 469-475.
4. Niederwieser, D.W., Appelbaum, F.R., Gastl, G., Gersdorf, E., Meister, B., Geissler, D., Tratkiewicz, J.A., Thaler, J. & Huber, C. (1990) Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. New England Journal of Medicine, 322, 1794-1796.
5. Pulsipher, M.A., Levine, J.E., Hayashi, R.J., Chan, K.W., Anderson, P., Duerst, R., Osunkwo, I., Fisher, V., Horn, B. & Grupp, S.A. (2005) Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplantation, 35, 361-367.
6. Smith, M.L., Cavenagh, J.D., Lister, T.A. & Fitzgibbon, J. (2004) Mutation of CEBPA in familial acute myeloid leukemia. New England Journal of Medicine, 351, 2403-2407.